Using the transcription factor inhibitor of DNA binding 1 to selectively target endothelial progenitor cells offers novel strategies to inhibit tumor angiogenesis and growth

Autoria(s): Mellick, Albert S.; Plummer, Prue N.; Nolan, Daniel J.; Gao, Dingchen; Bambino, Kathryn; Hahn, Mary; Catena, Raul; Turner, Vivian; McDonnell, Kevin; Benezra, Robert; Brink, Robert; Swarbrick, Alexander; Mittal, Vivek
Data(s)

15/09/2010
Identificador

http://hdl.handle.net/10536/DRO/DU:30063098
Idioma(s)

eng
Publicador

American Association for Cancer Research
Relação

http://dro.deakin.edu.au/eserv/DU:30063098/plummer-usingtranscription-2010.pdf

http://doi.org/10.1158/0008-5472.CAN-10-1142
Direitos

2010, American Association for Cancer Research
Palavras-Chave #tumor angiogenesis #endothelial progenitor cells (EPC) #tumor growth #transcription factor inhibitor of DNA binding 1 (Id1)
Tipo

Journal Article
Acesso ao item digital